Nationwide pleased with progress as profits remain 'consistent'

Josh White Sharecast | 11 Aug, 2017 10:38 | | |


Nationwide Building Society reported a dip in profit before tax for the first quarter on Friday, to £322m in the period from 5 April to 30 June, compared to £401m in the same period last year.

The UK’s largest building society described profit levels as “broadly consistent” with the prior period, after allowing for £26m in one-off gains in this quarter and a £100m non-recurring gain in the first quarter last year.

Its interim management statement showed an improved capital strength, with a CET1 ratio of 26.4% compared to 25.4% at the start of the quarter, and a UK leverage ratio of 4.4%, which was unchanged from 4 April.

The high street lender said it remained number one for customer satisfaction amongst its peer group, with a lead of 3.6%, and it claimed more people opened a current account with Nationwide than with any other provider, with more than one in five of all switchers reportedly choosing Nationwide.

Gross mortgage lending stood at £8.1bn - down from £8.6bn year-on-year - inclusive of prime mortgage lending of £7.3bn - up from £6.9bn.

Nationwide had a total mortgage market share of 13.0%, slipping from 15.0% a year ago.

Member deposit balances increased by £1.3bn in the period, which was down significantly from £2.6bn a year ago, with a market share of balance growth of 10.2%.

“Profit performance in the first quarter remained comfortably within our strategic target range and, after allowing for one-off items, was broadly consistent with the prior period,” commented Nationwide chief executive Joe Garner.

“Nationwide continued to bring the benefits of mutuality to more people.

“Independent research shows that in the first quarter we remained the UK's top choice for current accounts.”

Additionally, Garner pointed out that the society ended 2016 as the “highest net gainer of current accounts”, with more than twice as many net switchers as any other provider/

“[This was] the first time … a building society has overtaken the banks,” he added.

Garner said Nationwide continued to enjoy a “healthy share” of mortgage lending, with a gross market share of 13.0%.

He said it also introduced new steps to make membership more meaningful, offering an increased choice of preferential rates to “loyal savers”, and extending its 'recommend a friend' scheme.

“Nationwide remains number one for customer satisfaction among our high street peers, with our lead of 3.6% reflecting our commitment to member value and first class service.”

"Consumer confidence was an important barometer for the society, Garner added, saying that although the UK public had become less optimistic about the outlook for the economy generally, research conducted for its ‘Brexit Consumer Support Panel’ reportedly showed that the majority of consumers expect Brexit to leave their ability to access credit unchanged.

“It will be important for lenders to balance carefully credit supply with affordability as we seek to support the long-term interests of consumers in a responsible way through any potential economic slowdown ahead.

“In a period of potentially prolonged economic uncertainty and persistently low interest rates Nationwide continues to invest in products and services to support the long-term needs of our members.”

More news

17 Oct US close: Markets finish higher amid busy earnings season

US markets finished in the green on Tuesday, with the Dow closing just short of the 23,000 mark which it breached for the first time ever earlier in the session, amid a busy third quarter earnings season on Wall Street.

17 Oct Europe close: Stocks slip ahead of US Fed Beige Book

Stocks on the Continent finished slightly lower as investors bid their time ahead of the release of the US central bank's Beige Book on Wednesday, against the backdrop of fresh intra-day records on Wall Street's main benchmarks with the Dow Industrials having climbed above the 23,000 point mark for the first time ever.

17 Oct Buy Spain as political risk is 'overstated' - Credit Suisse

Spanish equities look unusually cheap, said Credit Suisse on Tuesday, as political risk is "overstated" and the country is on track for at least 3% growth, with employment, housing and construction all on a growth tear.

17 Oct London close: Stocks move lower even as Sterling slips

London stocks closed lower on Tuesday even as the pound fell back against the dollar, albeit following a brief pop higher after data showed inflation surged to a five-year high last month, amid somewhat dovish remarks from Bank of England policymakers.

17 Oct Director dealings: Beazley executive director sells after profit warning

Adrian Cox, executive director of risk insurance and reinsurance group Beazley, sold 180,009 shares in the company on Tuesday at the price of 500p per share.

17 Oct Credit Suisse cuts Tate and Lyle's target price, reiterates 'neutral' rating

Ahead of Tate & Lyle's interim results on 2 November, Credit Suisse updated its forecasts and cut its target price to 710p while reiterating its 'neutral' rating.

17 Oct US open: Dow Industrials clambers atop 23,000 mark for first time

The Dow Industrials climbed past the 23,000 points mark for the first time ever, as the third-quarter earnings season got into full swing, and then slipped lower.

17 Oct Higher inflation means benefits pain for households, says IFS

State benefits for roughly 10m UK families will be reduced by £450 a year in real terms after inflation reached its highest level in five years on Tuesday, the Institute for Fiscal Studies calculated.

17 Oct FTSE 250 movers: Virgin Money gains on update, Workspace boosted by JPM note

London's FTSE 250 was down 0.4% to 20,140.65 in afternoon trade on Tuesday.

17 Oct Johnson and Johnson raises full year targets after strong third quarter

Healthcare giant Johnson and Johnson posted higher than expected profits for the three months to 30 September thanks to increased demand for its new cancer drugs and the additional revenue afforded to the group from its June acquisition of Swiss biotech company Actelion.